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While carbon monoxide (CO) is considered toxic, low levels of endogenously produced CO
are protective against cellular injury induced by oxidative stress. Carboxyhaemoglobin
(COHb) levels have been associated with outcomes in critically ill adults. We aimed to
describe the distribution of carboxyhaemoglobin in critically ill children and the relationship
of these levels with clinical outcomes. This retrospective observational study was conducted
at a large tertiary paediatric intensive care unit (PICU). We included all children admitted to
the PICU over a two-year period who underwent arterial blood gas analysis. We measured
the following: (i) Population and age-related differences in COHb distribution; (ii) Change in
COHb over the first week of admission using a multi-level linear regression analysis; (iii)
Uni- and multivariable relationships between COHb and length of ventilation and PICU sur-
vival. Arterial COHb levels were available for 559/2029 admissions. The median COHb level
was 1.20% (IQR 1.00–1.60%). Younger children had significantly higher COHb levels (p-
value <2 x 10−16). Maximum Carboxyhaemoglobin was associated with survival 1.67 (95%
CI: 1.01–2.57; p-value = 0.02) and length of ventilation (OR 5.20, 95% CI: 3.07–7.30; p-
value = 1.8 x 10−6) following multi-variable analysis. First measured and minimum COHb
values were weakly associated with length of ventilation, but not survival. In conclusion, chil-
dren have increased COHb levels in critical illness, which are greater in younger children.
Higher COHb levels are associated with longer length of ventilation and death in PICU. This
may reflect increased oxidative stress in these children.
Introduction
Exogenous carbon monoxide (CO) has long been considered toxic due to competitive inhibi-
tion of haemoglobin oxygen binding. However, endogenous CO is increasingly being associ-
ated with beneficial physiological effects [1]. Heme is oxidised to produce CO, free iron and
biliverdin, a reaction catalysed by heme oxygenase (HO). Of the three known isoforms of HO,
HO-1 is highly induced by oxidative stress, it acts to limit damage from the oxidant heme [2].
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CO therefore, may be a biomarker of oxidative stress. Carbon monoxide can activate soluble
guanylate cyclase, and hence, the cyclic guanylate monophosphate (cGMP) signalling pathway.
This is thought to be a common signalling pathway for CO’s anti-apoptotic, anti-inflammatory
and vaso-active properties [3,4]. Protective effects of CO have been demonstrated in laboratory
models of sepsis, acute lung injury, organ transplantation and reperfusion injury [5–8]. In
vivo, CO is mostly eliminated in exhaled air, but a proportion remains bound to haemoglobin
—this is determined by the rate of CO production and minute ventilation [9].
Elevated levels of exhaled CO are associated with smoking, and patients with chronic respi-
ratory disease [10]. This suggests that exhaled CO may be a marker of lung injury. Elevated
exhaled CO levels have also been described in critically ill adults in the intensive care unit
(ICU) [11]. However, exhaled CO levels were correlated with arterial carboxyhaemoglobin
(COHb) and serum bilirubin levels, suggesting increased CO production due to increased sys-
temic HO activity rather than lung injury in critical illness [12].
Arterial COHb levels have previously been associated with outcomes in adult ICU patients.
Melley et al described a U-shaped relationship between ICU survival and COHb levels: risk
adjusted mortality was associated with a lower minimum and greater maximum COHb level
in patients post cardio-pulmonary bypass [13]. The authors hypothesised that an optimal
amount of CO conferred anti-inflammatory effects in critically ill patients: patients unable
to mount a HO-1 response to stress (e.g. due to genetic polymorphisms) may lack this anti-
inflammatory response. In patients with high COHb levels, high levels of oxidative stress may
account for the increased mortality. Alternatively, the deleterious effects of concomitant high
levels of free iron, itself reactive, may account for negative outcomes [14].
Fazekas et al similarly demonstrated the association between low COHb and mortality in
adult medical ICU patients [15]. A small study of COHb levels in preterm neonates did not
find associations between the presence and absence of sepsis but did find associations between
post-natal age and haemoglobin levels [16]. However, this is likely to be related to high levels
of haemolysis in the early neonatal period. There are no studies of COHb levels in critically ill
children. Increased HO-1 activity in children has been described in disease states such as obe-
sity [17] and haemolysis [18]. Therefore, similar responses as seen in adult ICU patients should
be expected. In the PICU setting, COHb levels are typically followed when CO poisoning is
suspected, though the values are routinely reported on standard blood gas analysis. Given the
recent literature on the association between beneficial physiological effects and endogenous
CO, we hypothesise that COHb levels in critically ill children will be linked to outcomes, such
as mortality and length of ventilation.
In this retrospective, observational study, we aimed to 1) evaluate the distribution of arterial
COHb in children admitted to a medical paediatric intensive care unit; 2) describe the trajec-
tory of arterial COHb levels over the first 7 days of admission; 3) seek associations between
arterial COHb and ICU outcomes: given the low rate of mortality on paediatric ICU, we also
sought associations between COHb and length of ventilated stay.
Methods
We conducted a retrospective, observational study using data from a single centre, 23-bedded
general (non-cardiac) paediatric intensive care unit (PICU). Data were collected from the elec-
tronic health records (Philips Intellivue Critical Care and Anaesthesia, Philips Electronics,
Amsterdam, the Netherlands) for all children following unplanned admission to PICU who
underwent arterial blood gas analysis between 1st January 2015 and 31st December 2016. All
children from neonates to 16 years were included. Arterial blood gas analysis was carried out
using the ABL 90 Flex Blood Gas analyser (Radiometer Medical, Bronshoj, Denmark). COHb
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is expressed as a fraction of total haemoglobin concentration, measured by co-oximetry. As a
majority of children undergo capillary sampling, with a potential of haemolysis at the point of
sampling, only arterial gas samples were considered. Venous samples were also excluded—
although arterio-venous correlation for COHb is excellent, the mean difference arterio-venous
of 0.15% (95% CI 0.13–0.45%) [19] may have confounded results for children with low COHb
levels. Children who underwent continuous veno-venous haemofiltration (CVVH) were also
excluded due to the likelihood of extra-corporeal haemolysis.
Time of collection and COHb level for each arterial gas sample analysed were collected.
For each patient who underwent arterial blood gas analysis, admission and discharge date and
time, minute ventilation, length of ventilation in days, status at discharge, age in months, sex
and Paediatric Index of Mortality-3 (PIM-3) score data were collected.
Continuous data were described as median and inter-quartile intervals. Differences
between age groups (<1 month, 1 month-1 year and >1 year of age) were analysed using the
Kruskal-Wallis test. The mean change in COHb over the first week of admission was evaluated
following multi-level regression analysis, using COHb as the dependent variable, day of admis-
sion, age, PIM-3 score and the minute ventilation as the fixed effect variables and the patient
and admission identifier as the random effect variables. The first COHb level following PICU
admission, maximum and minimum COHb levels during admission were analysed for rela-
tionship with length of ventilation and survival status at discharge. Univariate associations
with COHb levels were sought using Spearman’s correlation for length of ventilation, and
Mann-Whitney tests for survival at discharge. The predictive value for survival was also quan-
tified using receiver operating characteristic (ROC) curves. Linear and logistic regression anal-
ysis for length of ventilation and survival status at discharge were used respectively. Age and
PIM-3 score were used as confounders, with length of ventilation added as a confounder for
survival status. All data were analysed using Microsoft Excel (Microsoft Corp, Redmond, WA)
and r (www.r-cran.org).
The study was reviewed and approved by the UCL GOS Institute of Child Health Joint
Research and Development Office (ref 17BB36). As the investigators only accessed previously
collected, non-identifiable information/data under GAfREC 2011, the need for individual
patient consent was waived by the institutional research governance department. We have
uploaded the approval notification along with the manuscript files as Supporting Information.
Results
Over the 2-year period, there were 2027 admissions to PICU, 1239 (61.1%) of which were
unplanned. Of these, 619 (50.0%) had arterial blood gas analysis during their admission. Sixty-
one children required CVVH, leaving 558 (45.0%) children for further analysis. The baseline
characteristics of these children are shown in Table 1.
Distribution and age-related differences in COHb
The distribution of COHb values over the length of the admission is shown in Fig 1. The
median value was 1.20% (IQR: 1.00–1.60%). The median of the first value measured on PICU
was 1.00% (IQR: 0.70–1.30%) and of the maximum value during admission was 1.40% (IQR:
1.20–2.00%); while of minimum values it was 0.80% (IQR: 0.60–1.10%).
Age was categorised into children less than 1 month, between 1 month and 1 year, 1 to 5
years and 5–16 years, reflecting the proportion of admissions both locally and nationally. The
COHb values were significantly different between age categories (Kruskall-Wallis chi statistic
538.8; p-value <2 x 10−16). Younger children had wider variation in COHb levels with a ten-
dency towards higher values (Fig 2A). To ensure this was not explained by one category having
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arterial blood samples for a longer period of time, we also compared first COHb values. These
also significantly varied with age (Kruskal-Wallis chi statistic 47.1; p-value = 3.2 x 10−10), with
infants having higher values, and showing greater variation (Fig 2B).
Trajectory of COHb over the first 7 days of admission
The trajectory of COHb was evaluated using a multi-level regression model to control for each
patient admission. COHb increased over the first week. The mean COHb level, controlling
for PIM-3, age, and minute volume, was 1.17 (95% CI: 1.12–1.22) on day 0, compared to 1.43
(95% CI: 1.38–1.48) on day 3 and 1.62 (95% CI: 1.56–1.671) on day 7 (Table 2).
Table 1. Baseline characteristics of children following unplanned admissions to PICU who underwent arterial
blood gas analysis in 2015–16. Continuous variables expressed as medians and interquartile ranges and categorical
variables expressed as fractions and percentages.
Baseline Characteristic All Patients (n = 558�)
Age (months) 13.0 (1.0–61.5)
Female 237 (42.5%)
PIM-3 score 0.044 (0.014–0.095)
Mechanically ventilated 558 (100%)
Vaso-active drugs 300 (53.7%)
Length of ventilation (days) 4 (2–9)
Died 48 (8.6%)
�Children who required continuous veno-venous haemofiltration were excluded, leaving 558 children for final
analysis.
https://doi.org/10.1371/journal.pone.0209452.t001
Fig 1. Distribution of carboxyhaemoglobin (COHb) for children admitted to the paediatric intensive care unit in 2015–16 who underwent arterial
blood gas analysis. The continuous line shows the overall distribution for the cohort. The grey dashed line shows the distribution for the first measured
COHb value; the pink dotted line shows the distribution of maximum values during admission and the blue dashed line the minimum values during
admission.
https://doi.org/10.1371/journal.pone.0209452.g001
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Association between COHb and PICU outcomes
Associations between COHb and PICU outcomes were sought for (i) first measured COHb
values, (ii) maximum COHb values during admission, and (iii) minimum COHb values.
(i). The first and minimum COHb values were not significantly different between children
who survived and those who died at PICU discharge (Mann-Whitney p-value = 0.70
for first recorded COHb; 0.36 for minimum COHb). The maximum COHb was signifi-
cantly higher in children who died (median 1.60, IQR: 1.30–2.182) compared to those
who survived (median 1.40, IQR: 1.10–1.90; Mann-Whitney p-value = 0.04). (Fig 3) The
first measured COHb value poorly predicted survival at ICU discharge, with an area
under the ROC curve of 0.52. Following logistic regression, with age, PIM-3 score and
length of ventilation as confounders, first COHb did not independently predict survival
at discharge.
The first measured COHb value was poorly correlated with the length of ventilation (Fig
4), with a Spearman’s correlation coefficient of 0.28. Following linear regression with
Fig 2. The distribution of (A) all carboxyhaemoglobin (COHb) values throughout PICU stay (left), and (B) the first measured value of COHb
(right), according to age groups. There is a statistically significant difference between the groups for all COHb values (Kruskal-Wallis chi-squared
538.8; p-value<2 x 10−16) and first measured COHb values (Kruskal-Wallis chi-squared 47.1; p-value = 3.2 x 10−10).
https://doi.org/10.1371/journal.pone.0209452.g002
Table 2. Mean COHb levels for each day of admission in the first week following multi-level linear regression
analysis.
Day of admission Number of measurements Mean COHb (95% CI)
following multi-level regression analysis
Day 0 3272 1.17 (1.12–1.22)
Day 1 2199 1.27 (1.23–1.33)
Day 2 1738 1.38 (1.33–1.43)
Day 3 1243 1.43 (1.38–1.48)
Day 4 919 1.50 (1.45–1.55)
Day 5 662 1.52 (1.46–1.57)
Day 6 531 1.51 (1.45–1.56)
Day 7 428 1.62 (1.56–1.67)
The regression model was constructed with COHb as the dependent variable, days, minute volume, PIM-3 score and
age as the fixed effect variables and unique identifier for patient and admission as random effects variables. Day 0 is
defined as the first day of admission till midnight; following days are defined by the 24-hour period from midnight to
23:59.
https://doi.org/10.1371/journal.pone.0209452.t002
Arterial carboxyhaemoglobin levels in children admitted to PICU
PLOS ONE | https://doi.org/10.1371/journal.pone.0209452 March 7, 2019 5 / 10
age and PIM-3 as confounders, first COHb was significantly associated with length of
ventilation, with an odds ratio of 5.2 (95% CI: 2.4–8.0; p-value = 0.0003). However only
2.3% of the variation in length of ventilation was accounted for by the three variables
(i.e. R2 for COHb, age and PIM-3).
Fig 3. Box plot of measured COHb values and survival status at PICU discharge. The first, minimum and maximum COHb values (%) and the
survival status at PICU discharge are represented. Neither the first nor the minimum COHb values predicted survival status at ICU discharge. The
maximum COHb values were slightly better at predicting survival status at PICU discharge.
https://doi.org/10.1371/journal.pone.0209452.g003
Fig 4. Scatter plot of measured COHb values and length of ventilation (log transformed). The first, minimum and maximum COHb values (%) and
the length of ventilation in hours are represented.
https://doi.org/10.1371/journal.pone.0209452.g004
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(ii). The maximum COHb value predicted survival status slightly better, with maximum val-
ues being higher in the non-survivor group (Fig 3). The area under the ROC curve was
only 0.59, although after controlling for PIM-3 and age, the odds ratio for maximum
COHb was 1.67 (95% CI: 1.01–2.57; p-value = 0.02).
The maximum COHb was poorly correlated with length of ventilation (Spearman R
0.41) (Fig 4). Following multivariable analysis, maximum COHb was independently
associated with length of ventilation, with an odds ratio of 5.20 (95% CI: 3.07–7.30; p-
value = 1.8 x 10−6). The model R2 was 0.04, only slightly better than that for first COHb
(iii). The minimum COHb value poorly predicted survival status (Fig 3) with a correlation
coefficient of 0.14. Minimum COHb did not predict survival after multivariable analy-
sis.
Minimum COHb poorly predicted length of ventilation (Fig 4), both on uni-variable
(Spearman R 0.03) and multi-variable analysis.
We conducted further post-hoc analysis to determine whether a more subtle U-shaped
association exists between mortality and COHb levels. The risk adjusted mortality
according to 0.5% intervals of maximum COHb values were calculated, relative to the
risk adjusted mortality of the median category (i.e. 1.0–1.5%). Lower maximum COHb
values, however, had lower risk adjusted mortality (Fig 5).
Discussion
In this single centre retrospective observational study, we describe the distribution of arterial
COHb in children admitted to ICU. COHb levels rise with time mechanically ventilated.
There is weak association between mortality and maximum COHb during PICU admission,
Fig 5. Risk adjusted mortality according to categories of maximum COHb, relative to a maximum COHb value between 1.0–1.5%. The shaded
blue area represents the 95% confidence interval. Risk of mortality is adjusted for PIM-3, age, and length of ventilation. The U-shaped relationship
described by Melley et al in adults is not seen—COHb values< = 1.0 have a non-significantly lower risk adjusted mortality relative to children with a
maximum COHb between 1.0–1.5%.
https://doi.org/10.1371/journal.pone.0209452.g005
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and better association with length of ventilation. The association with length of ventilation
extends to the first measured COHb and the minimum COHb, both positively correlated,
albeit weakly.
The distribution of COHb was similar to that previously described in adult critical illness
(Melley and Fazekas described time-weighted mean values of 1.2 and 1.6% respectively, similar
value in our cohort is 1.3%). Younger children in our cohort demonstrated higher and more
variable COHb levels. This may reflect severity of illness: there was a significant difference in
the distribution of PIM scores, (median PIM scores: <1 month 0.078; 1 month- 1 year 0.044;
1 year-5 years 0.037; >5 years 0.035, Kruskal-Wallis chi-squared 42.7, p-value 2.9 x 10−9),
although the COHb values were highest in the 1 month to 1 year cohort. It is possible that neo-
nates are less able to mount the same degree of HO-1 response according to disease severity,
this needs further study.
Our data also demonstrated that COHb increases with time. It is therefore unsurprising
that the maximum COHb correlates with length of ventilation and mortality: the maximum
value is likeliest to occur prior to death. In our cohort this is confounded by the use of arterial
samples only: unlike in adult ICU, arterial catheters are likely to be in place only if the child is
still ventilated and critically unwell. It is quite possible that in children who are improving and
are extubated, the COHb falls. The rise in COHb may be in response to ongoing inflammation
from ventilator associated lung injury, or hyperoxia: HO-1 induction has been described in
response to hyperoxic damage [5]. We have previously described a bias towards higher satura-
tion targets in our centre [20], raising this mechanistic possibility.
Melley et al have previously described a U-shaped relationship between COHb and mortal-
ity in the ICU in a cohort with low mortality. This was not replicated in a general adult ICU
population with higher mortality. Although mortality was weakly associated with maximum
COHb in our cohort, there was no association with minimum COHb. However, as COHb
rises over time, and the sickest children in PICU die early [21,22], we suspected that any U-
shaped relationship would be subtler. Ultimately, our post-hoc analysis refuted such a U-
shaped relationship in this cohort. However, this may be confounded by the size of the cohort,
and the limitation to using only arterial COHb values.
Our study has several limitations. Our numbers are restricted by only including children
with arterial samples, although these are children are likely to have more severe disease, and
have a higher risk of mortality (U.K. baseline PICU mortality 3.8% cf 8.6% in our cohort).
We excluded children who required CVVH given the risk of extra-corporeal haemolysis.
However these children are likely to have greater severity of illness needing organ support,
and data from them may still be of value. Our cohort did not include children post cardio-
pulmonary bypass or on extracorporeal life support—this population need consideration,
but are likely to have different COHb profiles and associations (similar to differences
between the corresponding Fazekas and Melley cohorts). We did not consider haemoglobin
levels, which had been shown to be associated with COHb levels in premature neonates [16].
However, haemoglobin levels are likely to be more variable in the early neonatal period, with
greater haemolysis.
While CO has a potential protective effect through reducing reactive species mediated
inflammation; we did not see evidence of this effect in the outcomes in our population. Our
data provide a reference range for COHb values in critically ill children and demonstrate an
association between COHb and ICU outcomes. Further work may be needed to demonstrate
the effect on morbidity and recovery from critical illness. If indeed CO is protective, then this
may be used as a therapeutic strategy, either with the use of exogenous CO [23,24], or by the
pharmacological induction of HO-1 [25].
Arterial carboxyhaemoglobin levels in children admitted to PICU
PLOS ONE | https://doi.org/10.1371/journal.pone.0209452 March 7, 2019 8 / 10
Supporting information
S1 File. Approval Letter. Letter of approval from UCL GOS Institute of Child Health Joint
Research and Development Office.
(PDF)




Conceptualization: Ankur Chawla, Samiran Ray, Mark J Peters.
Data curation: Ankur Chawla, Samiran Ray, Mark J Peters.
Formal analysis: Ankur Chawla, Samiran Ray, Adela Matettore, Mark J Peters.
Investigation: Samiran Ray.
Methodology: Ankur Chawla, Samiran Ray.
Software: Samiran Ray.
Supervision: Mark J Peters.
Validation: Samiran Ray.
Writing – original draft: Ankur Chawla, Samiran Ray, Mark J Peters.
Writing – review & editing: Ankur Chawla, Samiran Ray, Adela Matettore, Mark J Peters.
References
1. Ghosh S, Gal J, Marczin N. Carbon monoxide: endogenous mediator, potential diagnostic and thera-
peutic target. Ann Med. 2010; 42(1):1–12. https://doi.org/10.3109/07853890903482877 PMID:
20092397
2. Ryter SW, Choi AM. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of
inflammation. Transl Res. 2016 Jan; 167(1):7–34. https://doi.org/10.1016/j.trsl.2015.06.011 PMID:
26166253
3. Otterbein LE, Bach FH, Alam J, Soares M, Lu HT, Wysk M, et al. Carbon monoxide has anti-inflamma-
tory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000 Apr; 6(4):422–8.
https://doi.org/10.1038/74680 PMID: 10742149
4. Kim SK, Joe Y, Chen Y, Ryu J, Lee J-H, Cho GJ, et al. Carbon monoxide decreases interleukin-1β lev-
els in the lung through the induction of pyrin. Cell Mol Immunol. 2017 Apr; 14(4):349–359. https://doi.
org/10.1038/cmi.2015.79 PMID: 26435068
5. Wang X, Wang Y, Kim HP, Nakahira K, Ryter SW, Choi AMK. Carbon monoxide protects against hyper-
oxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J Biol Chem.
2007 Jan 19; 282(3):1718–26. https://doi.org/10.1074/jbc.M607610200 PMID: 17135272
6. Mishra S, Fujita T, Lama VN, Nam D, Liao H, Okada M, et al. Carbon monoxide rescues ischemic lungs
by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target
genes. Proc Natl Acad Sci U S A. 2006 Mar 28; 103(13):5191–6. https://doi.org/10.1073/pnas.
0600241103 PMID: 16551742
7. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, et al. Carbon monoxide induces cytoprotec-
tion in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Am J Pathol.
2003 Jul; 163(1):231–42. https://doi.org/10.1016/S0002-9440(10)63646-2 PMID: 12819027
8. Murphy PB, Bihari A, Parry NG, Ball I, Leslie K, Vogt K, et al. Carbon monoxide and hydrogen sulphide
reduce reperfusion injury in abdominal compartment syndrome. J Surg Res. 2018 Feb; 222:17–25.
https://doi.org/10.1016/j.jss.2017.09.028 PMID: 29273369
Arterial carboxyhaemoglobin levels in children admitted to PICU
PLOS ONE | https://doi.org/10.1371/journal.pone.0209452 March 7, 2019 9 / 10
9. Coburn RF, Forster RE, Kane PB. Considerations of the physiological variables that determine the
blood carboxyhemoglobin concentration in man. J Clin Invest. 1965 Nov; 44(11):1899–910. https://doi.
org/10.1172/JCI105296 PMID: 5845666
10. Zhang Q, Li L, Smith M, Guo Y, Whitlock G, Bian Z, et al on behalf of China Kadoorie Biobank study col-
laboration. Exhaled carbon monoxide and its associations with smoking, indoor household air pollution
and chronic respiratory diseases among 512,000 Chinese adults. Int J Epidemiol. 2013 Oct; 42
(5):1464–75. https://doi.org/10.1093/ije/dyt158 PMID: 24057999
11. Scharte M, von Ostrowski TA, Daudel F, Freise H, Aken HV, Bone HG. Endogenous carbon monoxide
production correlates weakly with severity of acute illness. Eur J Anaesthesiol. 2006 Feb; 23(2):117–22.
https://doi.org/10.1017/S0265021505002012 PMID: 16426465
12. Morimatsu H, Takahashi T, Maeshima K, Inoue K, Kawakami T, Shimizu H, et al. Increased heme
catabolism in critically ill patients: correlation among exhaled carbon monoxide, arterial carboxyhemo-
globin, and serum bilirubin IXalpha concentrations. Am J Physiol Lung Cell Mol Physiol. 2006 Jan; 290
(1):L114–9. https://doi.org/10.1152/ajplung.00031.2005 PMID: 16100291
13. Melley DD, Finney SJ, Elia A, Lagan AL, Quinlan GJ, Evans TW. Arterial carboxyhemoglobin level and
outcome in critically ill patients. Crit Care Med. 2007 Aug; 35(8):1882–7. https://doi.org/10.1097/01.
CCM.0000275268.94404.43 PMID: 17568332
14. Suttner DM, Dennery PA. Reversal of HO-1 related cytoprotection with increased expression is due to
reactive iron. FASEB J. 1999 Oct; 13(13):1800–9. PMID: 10506583
15. Fazekas AS, Wewalka M, Zauner C, Funk G-C. Carboxyhemoglobin levels in medical intensive care
patients: a retrospective, observational study. Crit Care. 2012 Jan 11; 16(1):R6. https://doi.org/10.1186/
cc11138 PMID: 22236404
16. McArdle AJ, Webbe J, Sim K, Parrish G, Hoggart C, Wang Y, et al. Determinants of Carboxyhemoglo-
bin Levels and Relationship with Sepsis in a Retrospective Cohort of Preterm Neonates. PLoS One.
2016 Aug 23; 11(8):e0161784. https://doi.org/10.1371/journal.pone.0161784 PMID: 27552216
17. Carmona-Montesinos E, Velazquez-Perez R, Pichardo Aguirre E, Rivas-Arancibia S. Obesity, Oxida-
tive Stress, and Their Effect on Serum Heme Oxygenase-1 Concentrations and Insulin in Children
Aged 3 to 5 Years in a Pediatric Hospital of the Ministry of Health CDMX. Child Obes. 2016 Dec; 12
(6):474–481. https://doi.org/10.1089/chi.2016.0155 PMID: 27728771
18. Evans C, Orf K, Horvath E, Levin M, De La Fuente J, Chakravorty S, et al. Impairment of neutrophil oxi-
dative burst in children with sickle cell disease is associated with heme oxygenase-1. Haematologica.
2015 Dec; 100(12):1508–16. https://doi.org/10.3324/haematol.2015.128777 PMID: 26315932
19. Touger M, Gallagher EJ, Tyrell J. Relationship between venous and arterial carboxyhemoglobin levels
in patients with suspected carbon monoxide poisoning. Ann Emerg Med. 1995 Apr; 25(4):481–3. PMID:
7710152
20. Ray S, Rogers L, Raman S on behalf of the Oxy-PICU investigators. Liberal oxygenation in paediatric
intensive care: retrospective analysis of high-resolution SpO(2) data. Intensive Care Med. 2017 Jan; 43
(1):146–147. https://doi.org/10.1007/s00134-016-4606-y PMID: 27796402
21. Cvetkovic M, Lutman D, Ramnarayan P, Pathan N, Inwald D, Peters M. Timing of death in children
referred for intensive care with severe sepsis: implications for interventional studies. Pediatr Crit Care
Med. 2015 Jun; 16(5):410–7. https://doi.org/10.1097/PCC.0000000000000385 PMID: 25739013
22. Weiss SL, Balamuth F, Hensley J, Fitzgerald JC, Bush J, Nadkarni V, et al. The Epidemiology of Hospi-
tal Death Following Pediatric Severe Sepsis: When, Why, and How Children With Sepsis Die. Pediatr
Crit Care Med. 2017 Sep; 18(9):823–830. https://doi.org/10.1097/PCC.0000000000001222 PMID:
28549024
23. Bathoorn E, Slebos DJ, Postma DS, Koeter GH, van Oosterhout AJM, van der Toorn M, et al. Anti-
inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J.
2007 Dec; 30(6):1131–7. https://doi.org/10.1183/09031936.00163206 PMID: 17715164
24. Rosas IO, Goldberg HJ, Collard HR, El-Chemaly S, Flaherty K, Hunninghake GM, et al. A Phase II Clini-
cal Trial of Low-Dose Inhaled Carbon Monoxide in Idiopathic Pulmonary Fibrosis. Chest. 2017 Oct 31.
25. Espinoza JA, Leo´n MA, Ce´spedes PF, Gomez RS, Canedo-Marroquin G, Riquelme SA, et al. Heme
Oxygenase-1 Modulates Human Respiratory Syncytial Virus Replication and Lung Pathogenesis during
Infection. J Immunol. 2017 Jul 1; 199(1):212–223. https://doi.org/10.4049/jimmunol.1601414 PMID:
28566367
Arterial carboxyhaemoglobin levels in children admitted to PICU
PLOS ONE | https://doi.org/10.1371/journal.pone.0209452 March 7, 2019 10 / 10
